J&J Imbruvica gains EU approval for untreated Mantle Cell Lymphoma in transplant eligible patients Ruchika Sharma25 July 2025 12:40 PM ISTBeerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the European Commission (EC) has approved an...
Roche Itovebi gets European Commission nod in fight against advanced breast cancer Ruchika Sharma24 July 2025 2:30 PM ISTBasel: Roche has received approval from the European Commission for Itovebi (inavolisib), in combination with palbociclib (Ibrance) and...
JnJ Darzalex gets European Commission nod for high-risk smouldering multiple myeloma Ruchika Sharma24 July 2025 12:15 PM ISTBeerse: Janssen-Cilag International NV, a Johnson & Johnson company, has received approval from the European Commission (EC) for a new...
Bayer Nubeqa gets EU nod in third indication for advanced prostate cancer Ruchika Sharma22 July 2025 10:30 AM ISTBerlin: Bayer has received marketing authorization from the European Commission in the European Union (EU) for Nubeqa (darolutamide), an oral...
Biocon Biologics gets EU nod for bone disease treatments, including Osteoporosis, giant cell tumour of bone Ruchika Sharma3 July 2025 11:29 AM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced that the...
Aurobindo Pharma arm gets marketing nod for Dazublys from European Commission Ruchika Sharma2 July 2025 5:33 PM ISTHyderabad: Aurobindo Pharma has announced that CuraTeQ Biologics, a wholly owned step-down subsidiary of the company, has obtained marketing...
Bayer Eylea 8 mg with extended 6-month treatment interval approved in EU for retinal diseases Ruchika Sharma29 Jun 2025 11:00 AM ISTBerlin: Bayer has received approval from the European Commission (EC) for a label extension in the European Union (EU) for Eylea 8 mg...
Roche Evrysdi tablet gets European Commission approval for Spinal Muscular Atrophy Ruchika Sharma5 Jun 2025 2:00 PM ISTBasel: Roche has announced that the European Commission (EC) has approved a label extension for Evrysdi (risdiplam) to include a new,...
Takeda Adcertris combo approved by European Commission for newly diagnosed Stage IIb/III/IV Hodgkin Lymphoma Ruchika Sharma5 Jun 2025 11:30 AM ISTOsaka: Takeda has received approval from the European Commission (EC) for ADCETRIS (brentuximab vedotin) in combination with etoposide,...
Bristol Myers Squibb bags European Commission nod for Subcutaneous formulation of Opdivo across multiple solid tumor indications Ruchika Sharma29 May 2025 10:00 AM ISTPrinceton: Bristol Myers Squibb has received approval from the European Commission (EC) for a new Opdivo (nivolumab) formulation...
Bristol Myers Squibb bags European Commission approval for Opdivo combo in lung cancer treatment Ruchika Sharma18 May 2025 11:45 AM ISTPrinceton: Bristol Myers Squibb has announced that the European Commission (EC) has approved the perioperative regimen of neoadjuvant...
AstraZeneca Calquence plus chemoimmunotherapy approved in EU for 1st-line mantle cell lymphoma Ruchika Sharma7 May 2025 12:30 PM ISTCambridge: AstraZeneca has announced that Calquence (acalabrutinib) in combination with bendamustine and rituximab has been approved in the...
